ASH Management of Myelofibrosis in Adults 2026 Guideline - Summary of Key Recommendations

Clinical Guideline InSights · Oct 21, 2026 · 3m

The 2026 Management of Myelofibrosis in Adults guideling, highlighting a summary of key recommendations across JAK-inhibitor therapy, extended molecular testing, hematopoietic cell transplantation, and more.

Management of Myelofibrosis in Adults

American Society of Hematology

October 14, 2026

Guideline Summary: https://www.guidelinecentral.com/guideline/5283851/

Full-Text: https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2026021650/571415/American-Society-of-Hematology-2026-Guidelines-for

InSights Spotlight…